# CinRx Pharma

CinRx Pharma is an Asset Manager based in Cincinnati, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Cincinnati, United States
- **Region:** North America
- **Address:** 5375 Medpace Way, Cincinnati, OH 45227
- **Founded:** 2015
- **Assets under management:** Undisclosed
- **Website:** www.cinrx.com
- **LinkedIn:** https://www.linkedin.com/company/cinrx-pharma

## Regulatory record

- **Reports private funds:** No

## About

A hub and spoke biotech advancing a portfolio of high-impact medicines | CinRx Pharma is a biotech company advancing a diverse portfolio of high-impact medicines through clinical development with a unique hub-and-spoke business model. CinRx’s approach combines financing with the efficient progression of therapeutic candidates within its portfolio, each managed by CinRx’s central infrastructure and operating team. Current CinCos address areas of high unmet medical need including metabolic, gastrointestinal, and oncology.

## Sectors

- Biotechnology
- Pharmaceuticals

## People

- Jon Isaacsohn — Founder & Chief Executive Officer
- August Troendle — Founder & Chairman of the Board
- Brian Murphy — Chief Medical Officer
- Mary Bond — Chief Translational Science Officer
- Sally Dressman — Chief Administrative Officer

## Questions

### Who runs investment and asset-selection decisions at CinRx?

Founder and CEO Dr. Jon Isaacsohn leads strategic decisions, supported by Executive Director of Business Development Jason Westerheide and the Portfolio Management function headed by Mackenzie Pater. Asset evaluation draws on a systematic process that incorporates scientific, clinical, and operational screens, a logic inherited from the Medpace-trained leadership team.

### How is CinRx related to Medpace?

CinRx is chaired by August Troendle, the founder and CEO of Medpace, and is headquartered at Medpace’s Cincinnati campus. Several senior CinRx executives previously held roles at Medpace, and the firm references a “strategic CRO partnership” — effectively making Medpace a dedicated clinical-operations engine for CinRx’s portfolio companies.

## Related profiles

- [MMIS](https://altss.com/profile/mmis)
- [Randstad](https://altss.com/profile/randstad-nv)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cinrx-pharma

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology